Total Payments
$11,509
2024 Payments
$21.68
Companies
41
Transactions
737
Medicare Patients
1,765
Medicare Billing
$274,124
Payment Breakdown by Category
Food & Beverage$11,292 (98.1%)
Education$216.32 (1.9%)
Other$0.92 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,292 | 724 | 98.1% |
| Education | $216.32 | 11 | 1.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $0.92 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,062 | 183 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,584 | 100 | $0 (2022) |
| United Therapeutics Corporation | $1,078 | 40 | $0 (2022) |
| Genentech USA, Inc. | $812.57 | 47 | $0 (2022) |
| Grifols USA, LLC | $650.01 | 65 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $599.93 | 34 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $521.61 | 29 | $0 (2022) |
| Philips Electronics North America Corporation | $452.10 | 27 | $0 (2020) |
| Mylan Specialty L.P. | $294.21 | 16 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $290.27 | 17 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.68 | 1 | Novartis Pharmaceuticals Corporation ($21.68) |
| 2022 | $1,386 | 79 | AstraZeneca Pharmaceuticals LP ($208.80) |
| 2021 | $2,407 | 148 | United Therapeutics Corporation ($445.83) |
| 2020 | $1,842 | 120 | AstraZeneca Pharmaceuticals LP ($477.80) |
| 2019 | $1,965 | 146 | GlaxoSmithKline, LLC. ($499.74) |
| 2018 | $2,003 | 131 | GlaxoSmithKline, LLC. ($360.20) |
| 2017 | $1,884 | 112 | GlaxoSmithKline, LLC. ($318.32) |
All Payment Transactions
737 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/16/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 06/28/2022 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: PAH | ||||||
| 06/27/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Immunology | ||||||
| 06/27/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $8.38 | General |
| Category: Pulmonology | ||||||
| 06/24/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: IMMUNOLOGY | ||||||
| 06/23/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Respiratory | ||||||
| 06/20/2022 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Cardiology | ||||||
| 06/17/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/14/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.94 | General |
| 06/13/2022 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Inflammation | ||||||
| 06/10/2022 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: Respiratory | ||||||
| 06/09/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $75.45 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/09/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: RESPIRATORY | ||||||
| 06/08/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Pulmonology | ||||||
| 06/08/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $3.88 | General |
| Category: Pulmonology | ||||||
| 05/31/2022 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Inflammation | ||||||
| 05/26/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Respiratory | ||||||
| 05/26/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/24/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/21/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.60 | General |
| 05/19/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.38 | General |
| 05/17/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Immunology | ||||||
| 05/16/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Respiratory | ||||||
| 05/10/2022 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: RESPIRATORY | ||||||
| 05/10/2022 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 9 | 390 | 461 | $87,182 | $26,372 |
| 2021 | 11 | 729 | 962 | $181,743 | $64,254 |
| 2020 | 11 | 646 | 6,587 | $415,070 | $183,498 |
Total Patients
1,765
Total Services
8,010
Medicare Billing
$274,124
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 156 | $40,248 | $12,205 | 30.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $12,180 | $3,722 | 30.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 22 | $6,248 | $2,932 | 46.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 53 | 53 | $7,738 | $2,303 | 29.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 52 | 52 | $4,992 | $1,690 | 33.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 52 | 53 | $8,109 | $1,502 | 18.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 36 | 38 | $2,584 | $886.51 | 34.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 36 | 44 | $4,004 | $868.56 | 21.7% |
| 94762 | Test to measure oxygen level in blood using ear or finger device continuously overnight | Office | 2022 | 11 | 13 | $1,079 | $262.22 | 24.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 146 | 305 | $78,690 | $28,034 | 35.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 55 | 79 | $22,436 | $11,156 | 49.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 62 | 62 | $25,172 | $9,509 | 37.8% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 93 | 99 | $14,461 | $4,270 | 29.5% |
| 94727 | Determination of lung volumes using gas dilution or washout | Office | 2021 | 92 | 98 | $9,408 | $3,181 | 33.8% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 79 | 84 | $12,852 | $2,808 | 21.8% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 80 | 96 | $8,736 | $2,113 | 24.2% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 51 | 61 | $4,148 | $1,583 | 38.2% |
| 94762 | Overnight measurement of oxygen saturation in blood using ear or finger device | Office | 2021 | 49 | 55 | $4,565 | $1,099 | 24.1% |
| 94618 | Test for exercise-induced lung stress | Office | 2021 | 11 | 12 | $780.00 | $317.76 | 40.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 11 | 11 | $495.00 | $182.89 | 36.9% |
| J2182 | Injection, mepolizumab, 1 mg | Office | 2020 | 13 | 5,600 | $243,600 | $128,892 | 52.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 147 | 303 | $78,174 | $24,341 | 31.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 61 | 61 | $24,766 | $9,139 | 36.9% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2020 | 107 | 116 | $17,748 | $5,319 | 30.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 32 | 46 | $13,064 | $4,880 | 37.4% |
About Dr. Steven Marvel, M.D
Dr. Steven Marvel, M.D is a Pulmonary Disease healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588771323.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Marvel, M.D has received a total of $11,509 in payments from pharmaceutical and medical device companies, with $21.68 received in 2024. These payments were reported across 737 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($11,292).
As a Medicare-enrolled provider, Marvel has provided services to 1,765 Medicare beneficiaries, totaling 8,010 services with total Medicare billing of $274,124. Data is available for 3 years (2020–2022), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Salem, OR
- Active Since 08/25/2006
- Last Updated 11/30/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1588771323
Products in Payments
- NUCALA (Biological) $1,186
- SYMBICORT (Drug) $649.27
- Prolastin-C Liquid (Biological) $633.44
- Xolair (Biological) $592.12
- ORENITRAM (Drug) $509.76
- TRELEGY ELLIPTA (Drug) $426.54
- TYVASO (Drug) $410.90
- GLASSIA (Biological) $341.55
- DUPIXENT (Biological) $303.79
- OFEV (Drug) $290.29
- BREZTRI (Drug) $282.22
- XOLAIR (Biological) $246.55
- UPTRAVI (Drug) $224.41
- Esbriet (Biological) $220.45
- BREO (Drug) $204.10
- ANORO (Drug) $196.71
- Yupelri (Drug) $195.21
- COMBIVENT RESPIMAT (Drug) $193.38
- SMARTVEST (Device) $183.20
- BROVANA (Drug) $175.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Salem
James Witten, Md, MD
Pulmonary Disease — Payments: $167,998
Pulmonary Disease $167,998
David Killeen, D.o, D.O
Pulmonary Disease — Payments: $132,565
Pulmonary Disease $132,565
Nelson Greene, Md, MD
Pulmonary Disease — Payments: $33,883
Pulmonary Disease $33,883
Douglas Dorsey, M.d, M.D
Pulmonary Disease — Payments: $24,524
Pulmonary Disease $24,524
Matthew Cheng, Md, MD
Pulmonary Disease — Payments: $15,201
Pulmonary Disease $15,201
Kamran Firoozi, M.d, M.D
Pulmonary Disease — Payments: $7,489
Pulmonary Disease $7,489